Form 8-K - Current report:
SEC Accession No. 0001062993-15-005296
Filing Date
2015-10-06
Accepted
2015-10-06 16:02:19
Documents
5
Period of Report
2015-10-01
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 12753
2 EXHIBIT 3.1 exhibit3-1.htm EX-3.1 6703
3 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 5288
4 GRAPHIC exhibi1.jpg GRAPHIC 5428
5 GRAPHIC exhibi2.gif GRAPHIC 1953
  Complete submission text file 0001062993-15-005296.txt   36600
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-51652 | Film No.: 151146166
SIC: 8731 Services-Commercial Physical & Biological Research